Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAnaptysBio Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | -$1.11 | -$0.16 | -$0.64 |
| Q2 2026 | 4 | -$0.80 | -$0.10 | -$0.48 |
| Q3 2026 | 1 | -$0.56 | -$0.44 | -$0.49 |
| Q4 2026 | 2 | -$0.54 | -$0.43 | -$0.47 |
| Q1 2027 | 2 | -$0.07 | -$0.05 | -$0.06 |
| Q2 2027 | 1 | $0.06 | $0.08 | $0.07 |
| Q3 2027 | 1 | $0.29 | $0.37 | $0.32 |
| Q4 2027 | 2 | $1.15 | $1.46 | $1.27 |
AnaptysBio Inc Earnings Date And Information
AnaptysBio Inc last posted its earnings results on Tuesday, May 12th, 2026. The company reported $-1.84 earnings per share for the quarter, missing analysts' consensus estimates of $-0.64355 by $1.19645. The company had revenue of 25.56 M for the quarter and had revenue of 234.60 M for the year. AnaptysBio Inc has generated $0 earnings per share over the last year ($-0.46 diluted earnings per share) and currently has a price-to-earnings ratio of -67.14. AnaptysBio Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
AnaptysBio Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/12/2026 | Q1 2026 | -$0.64 | -$1.84 | -1.2 | $18.86 M | $25.56 M |
| 03/03/2026 | Q4 2025 | $0.89 | $1.79 | 0.9 | $87.04 M | $108.25 M |
| 11/04/2025 | Q3 2025 | -$1.06 | $0.54 | 1.6 | $21.92 M | $76.32 M |
| 08/06/2025 | Q2 2025 | N/A | -$1.34 | N/A | $11.68 M | $22.26 M |
| 05/05/2025 | Q1 2025 | -$1.30 | -$1.28 | 0.02 | $15.27 M | $27.77 M |
| 02/27/2025 | Q4 2024 | -$1.55 | -$0.77 | 0.78 | $7.78 M | $43.11 M |
| 11/05/2024 | Q3 2024 | N/A | -$1.14 | N/A | $8.21 M | $30.02 M |
| 08/05/2024 | Q2 2024 | -$1.20 | -$1.71 | -0.51 | $22.76 M | $10.97 M |
| 05/09/2024 | Q1 2024 | -$1.54 | -$1.64 | -0.1 | $4.00 M | $7.18 M |
| 03/11/2024 | Q4 2023 | N/A | -$1.57 | N/A | N/A | $9.01 M |
| 11/02/2023 | Q3 2023 | -$1.72 | -$1.41 | 0.31 | N/A | $3.32 M |
| 08/07/2023 | Q2 2023 | N/A | -$1.50 | N/A | N/A | $3.46 M |
| 05/11/2023 | Q1 2023 | -$1.04 | -$1.73 | -0.69 | N/A | $1.37 M |
| 03/01/2023 | Q4 2022 | -$0.92 | -$0.93 | -0.01 | N/A | $6.81 M |
| 11/08/2022 | Q3 2022 | -$0.47 | -$1.32 | -0.85 | N/A | $1.29 M |
| 08/08/2022 | Q2 2022 | -$0.98 | -$1.32 | -0.34 | N/A | $1.22 M |
| 05/04/2022 | Q1 2022 | -$0.99 | -$1.47 | -0.48 | N/A | $970.00 K |
| 03/07/2022 | Q4 2021 | $2.28 | -$1.18 | -3.46 | N/A | $1.01 M |
| 11/04/2021 | Q3 2021 | -$0.74 | -$0.24 | 0.5 | N/A | $20.89 M |
| 08/09/2021 | Q2 2021 | -$0.15 | -$0.02 | 0.13 | N/A | $30.03 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
AnaptysBio Inc Earnings: FAQ's
The conference call for AnaptysBio Inc's latest earnings report can be listened to online.
The conference call transcript for AnaptysBio Inc's latest earnings report can be read online.
AnaptysBio Inc (:ANAB) has a recorded annual revenue of $234.60 M.
AnaptysBio Inc (:ANAB) has a recorded net income of $-13,232,000.AnaptysBio Inc has generated $-0.46 earnings per share over the last four quarters.
AnaptysBio Inc (:ANAB) has a price-to-earnings ratio of -67.14 and price/earnings-to-growth ratio is 0.19.